Our co-director and professor of neurology Diederik van de Beek and his team responded quickly on the COVID-19 outbreak in the Netherlands. They started the first COVID-19 biobank in the country, by collecting all kinds of samples of COVID-19 patients. Currently, the Amsterdam UMC biobank contains 44.000 samples from 815 COVID-19 patients. Today, Van de Beek highlights the importance of the biobank for this new disease in the Dutch newspaper De Volkskrant.
The COVID-19 biobank is supported by the Amsterdam Corona Research Fund.
Read the article ‘Wat kunnen we leren van bloed en urine van covid-19 patiënten’ in the Dutch newspaper de Volkskrant here.